MedTrace Logo

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

NCT00666757 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2010-06-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.

Conditions

Interventions

DRUG

duloxetine

30-120 milligrams (mgs) orally daily for 12 weeks

DRUG

fluoxetine

20-80 mgs orally daily for 12 weeks

DRUG

citalopram

20-40 mgs orally daily for 12 weeks

DRUG

paroxetine

20-50 mgs orally daily for 12 weeks

DRUG

sertraline

50-200 mgs orally daily for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9AM - 5PM Eastern Time (UTC/GMT-5 hours, EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666757 on ClinicalTrials.gov